Featured
User access restricted after policy breach
Breath Work Aug 19, 2026
Mind Health Aug 18, 2026
Mind Health Aug 17, 2026
Discover how spinal muscular atrophy treatment has evolved with disease-modifying therapies and early intervention for...
Blood biomarkers are revolutionizing early Alzheimer detection, with a new P‑tau217 blood test matching PET...
The FDA will review tau PET imaging agent MK-6240 on August 13, seeking better Alzheimer...
Read our latest Gut Checks articles.
Ractigen Therapeutics completes patient enrollment in phase 2 clinical trial for ALS treatment using siRNA...
Spinal muscular atrophy treatment breakthroughs extend lives, but healthcare systems struggle to adapt to new...
New data regarding CIDP treatment with efgartigimod PH20 reveals long-term patient outcomes for clinicians based...
Discover how spinal muscular atrophy treatment has evolved with disease-modifying therapies and early intervention for better outcomes.
Discover how spinal muscular atrophy treatment has evolved with disease-modifying therapies and early intervention for better outcomes.
Spinal muscular atrophy care has evolved with disease-modifying drugs, enabling patients to live longer and require multidisciplinary healthcare teams.
Researchers discover new multiple sclerosis treatment using small molecule CN045 to promote remyelination activity.
Ractigen Therapeutics completes patient enrollment in phase 2 clinical trial for ALS treatment using siRNA therapy targeting SOD1 mutations.
FDA approves tau PET imaging agent Tauklarify for Alzheimer’s disease, backed by two large studies of 617 participants showing reliable...
Multiple sclerosis trial advances as Quantum BioPharma gains FDA clearance for Lucid‑MS phase 2 study, aiming to prove safety and...
Blood biomarkers are revolutionizing early Alzheimer detection, with a new P‑tau217 blood test matching PET scan accuracy, offering faster diagnosis...
Spinal muscular atrophy treatment breakthroughs extend lives, but healthcare systems struggle to adapt to new patient needs.
Discover the latest spinal muscular atrophy treatment options, including nusinersen and onasemnogene abeparvovec, for patients with SMA.
Discover the latest developments in Spinal Muscular Atrophy treatment during SMA Awareness Month, highlighting new disease-modifying therapies.